Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  head and neck cancer
Stage/Subtype:  head and neck cancer
Trial Type:  Supportive care
Results 1-25 of 33 for your search:
Start Over
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: 97115, NCI-2011-02073, CDR0000674208, WF 97115, WFU-97115, MDA-04-01, NCT01141231
Acupuncture in Preventing Radiation-Induced Xerostomia
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 2010-0584, NCI-2011-00306, NCT01266044
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients with Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: N11C5, NCI-2012-00692, CDR0000727295, NCCTG-N11C5, NCT01545687
Dapsone Gel, 5% in Reducing Rash in Patients with Metastatic Colorectal Cancer or Head and Neck Cancer Undergoing Chemotherapy with Cetuximab
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: 13-012, NCI-2013-01729, NCT01931150
Doxepin Hydrochloride or DLA Rinse in Reducing Oral Mucositis Pain in Patients with Head and Neck Cancer undergoing Radiation Therapy
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: A221304, NCI-2014-01877, NCT02229539
Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 603EUSA03, NCI-2010-01741, NCT00901732
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Phase: Phase II, Phase I
Type: Supportive care
Age: Not specified
Trial IDs: SAL 2012-0584, NCI-2014-00167, NCT01739634
Dynasplint Trismus System or Tongue Depressors in Reducing Trismus in Patients With Previously Treated Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 20 and over
Trial IDs: UAB0780, NCI-2011-03029, HNO 0602, NCT00507208
Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents
Phase: Phase II
Type: Educational/Counseling/Training, Supportive care
Age: 11 to 24
Trial IDs: ANUR1131, NCI-2012-00682, CDR0000726664, COG-ANUR1131, NCT01556256
Ketamine Hydrochloride in Reducing Pain in Patients With Mucositis Undergoing Chemoradiation or Radiation Therapy For Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: DMS 1022, NCI-2012-01913, D1022, NCT01653327
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Personalized Humidification Device in Improving Quality of Life and Reducing Side Effects in Patients With Head and Neck Cancer Undergoing Radiation Therapy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 13-10937, NCI-2013-01745, 072084, 13202, NCT01930435
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: IDR-OM-01, NCI-2013-02458, NCT02013050
Minocycline Hydrochloride in Reducing the Side Effects of Surgery in Patients with Head and Neck Cancer
Phase: Phase II
Type: Supportive care
Age: Over 18
Trial IDs: 2013-0510, NCI-2014-01979, NCT02055963
Vocal Function Exercises in Improving Voice Quality in Patients Who Have Undergone Radiation Therapy for Early Stage Glottic Cancers
Phase: Phase II
Type: Supportive care
Age: 40 to 75
Trial IDs: 2014-027, NCI-2014-01830, NCT02156518
A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & Neck
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: GT-001, NCI-2013-01796, NCT01921426
Laser Surgery or Electrocautery Surgery in Improving Pain and Quality of Life in Patients With Precancerous or Early Stage Oral Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-034, NCI-2011-00924, NCT01355926
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: OSU-07061, NCI-2011-03122, 2007C0090, NCT01473784
Implanted Fiducial Markers in Assessing Treatment Accuracy and Esophageal Toxicity in Patients with Solid Tumors Undergoing Spinal Stereotactic Radiosurgery
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 2012-0190, NCI-2012-01244, NCT01624220
Dexamethasone in Reducing Oral Pain and Dry Mouth after Surgery in Patients with Oropharyngeal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 andover
Trial IDs: 8071, NCI-2012-02780, CPC-12095-L, CR00021919, NCT01748942
Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer
Phase: No phase specified
Type: Diagnostic, Supportive care
Age: 40 to 89
Trial IDs: CCCWFU 97312, NCI-2012-02165, NCT01767961
Transoral Robotic Surgery in Treating Patients with Oropharyngeal or Supraglottic Squamous Cell Carcinoma
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: SCCA-TORS-2012, NCI-2013-01936, 16376, NCT01819480
Hatha Yoga in Improving Physical and Emotional Health in Head and Neck Cancer Survivors
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: VICC SUPP 1282, NCI-2013-01860, 121357, DOERSAJK04302014124530, NCT01951664
Start Over